Anthony Varca just graduated from the Harvard Chemical Biology PhD program, where he worked in the Buhrlage lab. His research has focused on the design and implementation of a high-throughput screen and orthogonal validation assays towards the identification of selective small molecule DUB inhibitors. Subsequent work has focused on the optimization of screening hits into small molecule probe compounds for studying DUBs' function and role in disease.